VAERS reports by lot

Moderna COVID-19 lot 007J212A: VAERS reports

77 VAERS reports list lot 007J212A as a Moderna COVID-19 vaccine, received between 2022-01-18 and 2024-01-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
77
Reports
25%
Marked serious
2
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8026%
Cardiac / Cardiovascular5618%
Gastrointestinal4615%
Neurological268%
Allergic / Anaphylactic248%
Injection-site / Local reaction206%
Respiratory196%
Musculoskeletal145%
Dermatological (non-injection-site)134%
Psychiatric / Neuropsychiatric62%
Autoimmune / Immune-mediated52%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oklahoma7
California6
Florida6
Arizona5
Illinois5
Virginia5
Texas5
Washington3
Oregon3
Arkansas3
New York2
Maryland2

Reports by month received

2022-0111
2022-0223
2022-0310
2022-048
2022-054
2022-063
2022-075
2022-083
2023-013
2023-031
2023-041
2023-081
2023-091
2023-101
2024-012

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.